September 2026
The global genomic biomarker market size was valued at USD 6.44 billion in 2026 and is projected to reach around USD 11.63 billion by 2035, registering a notable CAGR of 6.77%.
September 2026
The biomarker discovery outsourcing services market reached USD 20.82 billion in 2026, featuring leading biomarker discovery outsourcing services market companies such as Eurofins Scientific, Charles River Laboratories, ICON plc.
September 2026
The orphan disease biomarkers market expands with advancements in genomics, proteomics, and bioinformatics for rare conditions.
September 2026
The global single-cell genomics market is growing as advanced sequencing technologies enable high-resolution analysis of individual cells.
September 2026
The global proteomic biomarkers market size is growing as advanced proteomics enhances disease diagnosis, prognosis, and personalized therapy.
September 2026
The renal biomarkers market size was evaluated at USD 1.90 billion in 2026 and is projected to attain around USD 3.57 billion by 2034, with a solid CAGR of 8.22%.
September 2026
The global genomics in cancer care market size was evaluated at USD 28.32 billion in 2026 and is predicted to hit around USD 108.69 billion by 2035, growing at a CAGR of 28.32%.
September 2026
The circulating biomarkers market size reached USD 5.78 billion in 2026, with leading circulating biomarkers market companies including Abbott Laboratories, Becton, Dickinson and Company.
September 2026
The global neurogenomics market size was estimated at USD 2.34 billion in 2026 and is expected to hit around USD 9.06 billion by 2035, growing at a CAGR of 16.25% from 2026 to 2035.
September 2026
The global precision genomic testing market size is valued at USD 20.55 billion in 2026 and is expected to hit around USD 69.72 billion by 2035, growing at a CAGR of 14.57%.
September 2026
The global metabolomics biomarker market size was evaluated at USD 3.72 billion in 2026 and is predicted to hit around USD 10.85 billion by 2035, growing at a CAGR of 12.64%.
September 2026
The global personalized medicine biomarkers market size is projected to hit around USD 92.22 billion by 2035 from USD 25.51 billion in 2026 with a CAGR of 15.39%.
September 2026
The metagenomic sequencing market size was evaluated at USD 4.35 billion in 2026 and is predicted to hit around USD 19.08 billion by 2035, growing at a CAGR of 17.95%.
September 2026
The global AI-enabled non-invasive biomarker sensors market is growing as AI-powered sensors transform disease detection, monitoring, and personalized healthcare.
September 2026
The artificial intelligence in genomics market size is projected to hit around USD 25,860.87 million by 2035 from USD 1,503.86 million in 2026 with a CAGR of 37.3%.
September 2026
The consumer genomics market size was valued at USD 3.17 billion in 2026 and it is expected hit around USD 18.83 billion by 2034 with a CAGR of 24.95%.
September 2026
The global cancer biomarkers market size was estimated at USD 17.49 billion in 2026 and is projected to hit around USD 47.14 billion by 2035 with a CAGR of 11.71%.
September 2026
The global pharmacogenomics market size is projected to hit around USD 46.29 billion by 2035 from USD 21.41 billion in 2025 and expand at a CAGR of 8.98%.
September 2026
The global veterinary biomarkers market size is estimated to hit around USD 4.13 billion by 2035 increasing from USD 1.40 billion in 2026, with a CAGR of 12.79%.
September 2026
The global digital biomarkers market size calculated at USD 6.19 billion in 2026 and is projected to hit around USD 36.98 billion by 2035 with a CAGR of 22.05%.
September 2026
The global wellness genomics market size was calculated at USD 33.73 billion in 2026 and is expected to worth around USD 95.56 billion by 2034 with a CAGR of 13.98%.
September 2026
The global epigenomics market size was estimated at USD 22.65 billion in 2026 and is expected to hit around USD 77.29 billion by 2035, growing at a CAGR of 14.7%.
September 2026
The global multiplex biomarker imaging market size is projected to hit around USD 1,780.14 million by 2035 from USD 659.01 million in 2026 with a CAGR of 11.70%.
September 2026
The global spatial genomics and transcriptomics market size is estimated to hit around USD 1,003.66 million by 2035 from USD 363 million in 2026, with a CAGR of 11.99%.
September 2026
The global predictive biomarkers market size is valued at USD 34.32 billion in 2026 and is predicted to hit around USD 155.53 billion by 2035, at a CAGR of 18.34%.
September 2026
The global biomarkers market size was valued at USD 107.90 billion in 2026 and is expected to hit around USD 355.72 billion by 2035 with a CAGR of 14.21%.
September 2026
The global genomics market size was valued at USD 51.52 billion in 2026 and is projected to hit around USD 185.57 billion by 2035 with a notable CAGR of 15%
September 2026
The cns biomarkers market size was USD 8.81 billion in 2026, with leading cns biomarkers market players including F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Bio-Rad Laboratories, Quanterix Corporation.
September 2026
The global nutrigenomics market size is accounted to hit around USD 2,972.94 million by 2035 increasing from USD 720.41 million in 2026, with a CAGR of 17.10%.
September 2026
The global FFPE tissue samples for genomics study and analysis market size is estimated to hit around USD 1,548.29 million by 2034 from USD 1,036.05 million in 2026 , with a CAGR of 5.15%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com